Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice. - Liu Y; Reiken S; Dridi H; Yuan Q; Mohammad KS; Trivedi T; Miotto MC; Wedderburn-Pugh K; Sittenfeld L; Kerley Y; Meyer JA; Peters JS; et al. (Science translational medicine, 2023)